Literature DB >> 2322995

Comparison of initiation potential of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in an in vivo carcinogen bioassay system.

H Tsuda1, S Takahashi, S Yamaguchi, K Ozaki, N Ito.   

Abstract

A new approach to low-dose assessment of carcinogenic potential was applied to food contaminant pyrolysis products. Single intragastric doses of the carcinogenic pyrolysates, 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) or 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline MeIQx), were given 12 h after two-thirds partial hepatectomy (PH) to F344 male rats. Two weeks thereafter the animals were placed on a basal diet containing 0.05% phenobarbital (PB) for 6 weeks combined with an i.p. administration of D-galactosamine (300 mg/kg) to facilitate growth of initiated cells. Both IQ and MeIQx clearly caused initiation of hepatocarcinogenesis as revealed by induction of preneoplastic placental-form glutathione-S-transferase-positive (GST-P+) hepatocyte foci composed of more than three cells (approximately 30 microns in diameter). A similar protocol without performance of PH before pyrolysate administration gave a positive result only for the IQ-treated group indicating that cell proliferation is essential during the low-dose, one-shot initiation step. IQ was found to be two to three times more potent in inducing GST-P+ foci using both protocols. The current approach could find application in practical carcinogenicity screening of chemicals, for which only small amounts are available.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2322995     DOI: 10.1093/carcin/11.4.549

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  7 in total

1.  Lack of carcinogenicity of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in cynomolgus monkeys.

Authors:  K Ogawa; H Tsuda; T Shirai; T Ogiso; K Wakabayashi; D W Dalgard; U P Thorgeirsson; S S Thorgeirsson; R H Adamson; T Sugimura
Journal:  Jpn J Cancer Res       Date:  1999-06

2.  Organotropic chemopreventive effects of n-3 unsaturated fatty acids in a rat multi-organ carcinogenesis model.

Authors:  H Toriyama-Baba; M Iigo; M Asamoto; Y Iwahori; C B Park; B S Han; N Takasuka; T Kakizoe; C Ishikawa; K Yazawa; E Araki; H Tsuda
Journal:  Jpn J Cancer Res       Date:  2001-11

3.  Chemopreventive effects of beta-carotene, alpha-tocopherol and five naturally occurring antioxidants on initiation of hepatocarcinogenesis by 2-amino-3-methylimidazo[4,5-f]quinoline in the rat.

Authors:  H Tsuda; N Uehara; Y Iwahori; M Asamoto; M Iigo; M Nagao; K Matsumoto; M Ito; I Hirono
Journal:  Jpn J Cancer Res       Date:  1994-12

4.  Effects of chronic administration of low doses of 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline on glutathione S-transferase placental form-positive foci development in the livers of rats fed a choline-deficient diet.

Authors:  H Sone; K Wakabayashi; H Kushida; M Ochiai; T Sugimura; M Nagao
Journal:  Jpn J Cancer Res       Date:  1993-08

5.  Decreased levels of 2-amino-3-methylimidazo[4,5-f]quinoline-DNA adducts in rats treated with beta-carotene, alpha-tocopherol and freeze-dried aloe.

Authors:  N Uehara; Y Iwahori; M Asamoto; H Baba-Toriyama; M Iigo; M Ochiai; M Nagao; M Nakayama; M Degawa; K Matsumoto; I Hirono; H Beppu; K Fujita; H Tsuda
Journal:  Jpn J Cancer Res       Date:  1996-04

6.  Down-regulation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-induced CYP1A2 expression is associated with bovine lactoferrin inhibition of MeIQx-induced liver and colon carcinogenesis in rats.

Authors:  Ken-ichi Fujita; Takamasa Ohnishi; Kazunori Sekine; Masaaki Iigo; Hiroyuki Tsuda
Journal:  Jpn J Cancer Res       Date:  2002-06

7.  Demonstration of initiation potential of carcinogens by induction of preneoplastic glutathione S-transferase P-form-positive liver cell foci: possible in vivo assay system for environmental carcinogens.

Authors:  H Tsuda; K Matsumoto; H Ogino; M Ito; I Hirono; M Nagao; K Sato; R Cabral; H Bartsch
Journal:  Jpn J Cancer Res       Date:  1993-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.